Efficacy of Rituximab as Adjunctive Therapy to Immunosuppressive Agents in Adult Primary Focal Segmental Glomerulosclerosis
RTX shows promise in treating primary FSGS, particularly in steroid-dependent patients, those with less severe nephrotic syndrome, and previous responders. RTX offers durable responses for most patients, but long-term management remains challenging in those who relapse and need retreatment.
Authors
- Rabeh Khairy Saleh (ORCID: https://orcid.org/0009-0007-6979-838X)
- Shereen Mohammed Mohammed Elsaghir
- Thekra Mohamed
- Basma Fathy
- Esmat Fathi (ORCID: https://orcid.org/0000-0001-8386-6827)
- Rasha Nazih Yousef (ORCID: https://orcid.org/0000-0002-1694-4968)
- Nicolas Toni (ORCID: https://orcid.org/0000-0001-5585-268X)
- A. M. S. Mahdy (ORCID: https://orcid.org/0000-0003-2218-5408)
- S. Abdelrazek (ORCID: https://orcid.org/0009-0005-2428-3599)
- Ayman Ahmed Abd Rabou
- Osama Mohamed (ORCID: https://orcid.org/0009-0009-7627-0617)
- Manar M. Sayed (ORCID: https://orcid.org/0009-0009-7698-3510)
- Mohamed Ahmed Abdelsamie
- H. M. Mohammed
- Aml Azzam
- Marwa Ibrahim Mohamed
- Reem Y Abdelazeem Elgarhy
Institutions
- Minia University (EG)
Publication Details
- Journal
- Kidney International Reports
- Published
- 2025-09-04
- DOI
- https://doi.org/10.1016/j.ekir.2025.08.046
- Primary Topic
- Renal Diseases and Glomerulopathies
- Type
- article
- Field-Weighted Citation Impact
- 0.00